BIOFORCE NANOSCIENCES HOLDINGS, INC.
BFNH · OTCMCIK 1310488fmd_1FW6K7PJCGB206F1ZYD4YMKEMQManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 37 periods
Latest annual · FY2025
Millions- Net income
- (1)
Latest quarter · Q3 FY2026
Millions- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Net income | -$1.3 million | -$490,437 | 10-K 2026-04-15 · proof | |
| Cash from operating activities | -$65,150 | -$61,250 | 10-K 2026-04-15 · proof | |
| Total assets | $786 | $862 | -8.8% | 10-K 2026-04-15 · proof |
| Total liabilities | $619,329 | $2.3 million | -73.1% | 10-K 2026-04-15 · proof |
| Cash and cash equivalents | $786 | $862 | -8.8% | 10-K 2026-04-15 · proof |
- What was BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s net income in fiscal 2025?
- BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported net income of -$1.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$490,437 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s cash from operating activities in fiscal 2025?
- BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported cash from operating activities of -$65,150 for fiscal 2025 (the year ended Dec 31, 2025), against -$61,250 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s total assets?
- As of Dec 31, 2025, BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported total assets of $786, against $862 a year earlier (-8.8%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s total liabilities?
- As of Dec 31, 2025, BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported total liabilities of $619,329, against $2.3 million a year earlier (-73.1%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)'s cash and cash equivalents?
- As of Dec 31, 2025, BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported cash and cash equivalents of $786, against $862 a year earlier (-8.8%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BFNH&period_type=annual&limit=5"Information only, not investment advice.